Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

ANGLE plc has "major breakthrough" for Parsortix

Andrew Newland, CEO of ANGLE plc (LON:AGL), tells Proactiveinvestors that the company has achieved a "major breakthrough" in the potential use of its Parsortix non-invasive cancer diagnostic product. Andrew discusses what it means for the company and what investors should now watch out for.
 
Meet Harvest Minerals at our event, London, 16 July 2015. Register here »
no_picture_pai.jpg


Register here to be notified of future ANGLE plc articles

Timeline

© Proactive Investors 2015